Ads
related to: novartis- Contact Us
Contact a PYLARIFY sales
representative to stay updated.
- Resources for PYLARIFY
Discover downloadable guides for
health care professionals.
- PYLARIFY Imaging Sites
Find or register a PYLARIFY
imaging site.
- PYLARIFY Case Studies
Review actual case study
findings for PYLARIFY.
- Contact Us
Search results
Exploring Swiss Dividend Stocks In May 2024
Simply Wall St. via Yahoo Finance· 10 hours agoAmidst a cautious atmosphere driven by inflation concerns and interest rate outlooks, the Swiss market experienced a downturn, with the benchmark SMI...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 3 hours agoThe eye-care market has attracted interest from pharmaceutical companies. Last year, Bausch + Lomb...
Data breach at medical giant Cencora exposes info from multiple drug companies
TechRadar· 2 days agoAlmost a dozen pharmaceutical companies, including several major players, have lost sensitive...
Tenecteplase Beneficial in Late LVO Stroke Except EVT Access
Medscape· 9 hours agoTenecteplase improved functional outcome in patients with LVO presenting beyond 4.5 hours who had...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoAcne Vulgaris Market to Register Sustainable Growth by 2034, Examines DelveInsight | Key Companies - Dermata Therapeutics, AstraZeneca, Novartis Pharmaceuticals, UCB Pharma ...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 5 days agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 6 days agoThere's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted ...
May 2024 Guide To Japanese Growth Companies With High Insider Ownership
Simply Wall St. via Yahoo Finance· 10 hours agoAs of May 2024, the Japanese market has shown resilience amidst global economic fluctuations, with a...
D.C. Circuit Holds 340B Program Does Not Prohibit Drug Manufacturers from Imposing Contract Pharmacy...
JD Supra· 5 days agoAlthough the court noted that the conditions imposed by Novartis and United Therapeutics Corporation on covered entities did not violate the 340B statute, it acknowledged ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 6 days agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
